Breakthrough Award Levels 1 and 2 II (BTA12-2)
Applications to the Fiscal Year 2022 (FY22) Breast Cancer Research Program (BCRP) are being solicited by the U.S. Army Medical Research Acquisition Activity (USAMRAA) using delegated authority provided by United States Code, Title 10, Section 4001 (10 USC 4001). The execution management agent for this program announcement is the Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Development Command (USAMRDC). The BCRP was initiated in FY92 to support innovative, high-impact research, with a mission of ending breast cancer for Service Members, Veterans, and the general public. Appropriations for the BCRP from FY92 through FY21 totaled $3.94 billion. The FY22 appropriation is $150 million (M).
The BCRP challenges the scientific community to design research that will address the urgency of ending breast cancer. Specifically, the BCRP seeks to accelerate high-impact research with clinical relevance, encourage innovation and stimulate creativity, and facilitate productive collaborations.
Pre-Application (Letter of Intent): September 22, 2022 5:00 p.m. Eastern Time
Application: October 6, 2022 11:59 p.m. Eastern Time
Level 1: $450,000 with a single PI or $750,000 if applying under the Partnering PI Option
Level 2: $1.5M for applications with a single PI or $2.0M if applying under the Partnering PI Option
Era of Hope Scholar Award II (EOHS-2)
Pre-Applicaiton (Letter of Intent): September 22, 2022 5:00 p.m. Eastern Time
Confidential Letters of Recommendation Submission Deadline: October 11, 2022 5:00 p.m. Eastern Time